ABT vs JBTM · P/E 25, rev $44.33B vs P/E 39, rev $1.92B
Abbott Laboratories (ABT) versus JBTMarel Corp (JBTM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
JBTMarel Corp (JBTM) is a specialty industrial machinery company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported JBTM revenue for 2026-06-30 was $1.92B. Net income was $73.0M. JBTM currently screens at market cap $6.59B and trailing P/E 39.0.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. JBTM currently screens at market cap $6.59B and trailing P/E 39.0.
Not investment advice. Open the ABT and JBTM stock pages for the full models.
Not investment advice.